Send to

Choose Destination
J Thromb Haemost. 2012 Mar;10(3):500-2; author reply 502-4. doi: 10.1111/j.1538-7836.2011.04579.x.

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial: a rebuttal.

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center